• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.

作者信息

Livingston R B

出版信息

Cancer Treat Rev. 1977 Sep;4(3):153-65. doi: 10.1016/s0305-7372(77)80022-4.

DOI:10.1016/s0305-7372(77)80022-4
PMID:73419
Abstract
摘要

相似文献

1
Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
Cancer Treat Rev. 1977 Sep;4(3):153-65. doi: 10.1016/s0305-7372(77)80022-4.
2
Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
Eur J Cancer (1965). 1977 Apr-May;13(4-5):425-8. doi: 10.1016/0014-2964(77)90096-2.
3
Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
Cancer Lett. 1975 Nov;1(2):97-102. doi: 10.1016/s0304-3835(75)95630-x.
4
Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
Cancer Treat Rep. 1977 Jan-Feb;61(1):59-64.
5
[Prognostic factors in the chemotherapy of bronchial cancers].[支气管癌化疗中的预后因素]
Schweiz Med Wochenschr. 1974 Feb 23;104(8):268-71.
6
Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma.
Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):377-83.
7
[Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
Prax Klin Pneumol. 1980 Dec;34(12):719-23.
8
Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Cancer Treat Rep. 1976 Jan;60(1):61-8.
9
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
Cancer Treat Rep. 1978 Mar;62(3):327-32.
10
Chemo-immunotherapy for unresectable bronchogenic carcinoma.不可切除支气管源性癌的化学免疫疗法
Cancer Treat Rep. 1978 May;62(5):681-7.

引用本文的文献

1
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer.脂质体顺铂与顺铂在非鳞状非小细胞肺癌中的比较。
Cancer Chemother Pharmacol. 2011 Oct;68(4):945-50. doi: 10.1007/s00280-011-1572-5. Epub 2011 Feb 8.
2
Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinoma.非特异性免疫因素对晚期支气管源性癌预后的影响。
Cancer Immunol Immunother. 1982;13(2):140-4. doi: 10.1007/BF00205315.
3
Bronchial artery infusion of mitomycin C in carcinoma of the lung.
Cardiovasc Intervent Radiol. 1983;6(2):86-96. doi: 10.1007/BF02552778.
4
Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.异环磷酰胺联合用药（依托泊苷或顺铂）治疗非小细胞肺癌的经验。
Cancer Chemother Pharmacol. 1986;18 Suppl 2:S34-9. doi: 10.1007/BF00647449.
5
Chemosensitivity testing of human lung cancer cell lines using the MTT assay.采用MTT法对人肺癌细胞系进行化学敏感性测试。
Br J Cancer. 1988 Jun;57(6):540-7. doi: 10.1038/bjc.1988.125.